News for Healthier Living

New Drug Candidate Reverses Metabolic Liver Disease and Fibrosis, Pre-Clinical Data Shows

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita Therapeutics that has the potential to prevent and reverse liver fibrosis -- a dangerous, disease-induced build-up of scar tissue in the liver that often leads to cancer.

January 13, 2026


January 14 2026

January 13 2026

January 12 2026

January 11 2026

January 10 2026

January 9 2026

January 8 2026

January 7 2026

January 6 2026

January 5 2026

January 4 2026

January 3 2026

January 2 2026

January 1 2026

December 31 2025